共 16 条
Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12
被引:178
作者:
Hosaka, Takeshi
[2
]
Ohnishi-Kameyama, Mayumi
[2
]
Muramatsu, Hideyuki
[1
]
Murakami, Kana
[1
]
Tsurumi, Yasuhisa
[1
]
Kodani, Shinya
[2
]
Yoshida, Mitsuru
[2
]
Fujie, Akihiko
[1
]
Ochi, Kozo
[2
]
机构:
[1] Astellas Pharma Inc, Fermentat Res Labs, Tsukuba, Ibaraki, Japan
[2] Natl Food Res Inst, Tsukuba, Ibaraki 305, Japan
关键词:
COMPLETE GENOME SEQUENCE;
STREPTOMYCES-COELICOLOR A3(2);
ANTIBIOTIC PRODUCTION;
ACTIVATION;
RESISTANCE;
LIVIDANS;
MUTANT;
D O I:
10.1038/nbt.1538
中图分类号:
Q81 [生物工程学(生物技术)];
Q93 [微生物学];
学科分类号:
071005 ;
0836 ;
090102 ;
100705 ;
摘要:
We show that selection of drug-resistant bacterial mutants allows the discovery of antibacterial compounds. Mutant strains of a soil-isolated Streptomyces species that does not produce antibacterials synthesize a previously unknown class of antibacterial, which we name piperidamycin. Overall, 6% of non-Streptomyces actinomycetes species and 43% of Streptomyces species that do not produce antibacterials are activated to produce them. The antibacterial-producing mutants all carried mutations in RNA polymerase and/or the ribosomal protein S12.
引用
收藏
页码:462 / 464
页数:3
相关论文